Follow this preprint

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, Bo Meng, Rawlings Datir, Alexandra C. Walls, Steven A. Kemp S, Jessica Bassi, Dora Pinto, Chiara Silacci Fregni, Siro Bianchi, M. Alejandra Tortorici, John Bowen, Katja Culap, Stefano Jaconi, Elisabetta Cameroni, Gyorgy Snell, Matteo S. Pizzuto, Alessandra Franzetti Pellanda, Christian Garzoni, Agostino Riva, The CITIID-NIHR BioResource COVID-19 Collaboration, Anne Elmer, Nathalie Kingston, Barbara Graves, Laura E McCoy, Kenneth GC Smith, John R. Bradley, Nigel Temperton, Lourdes Ceron-Gutierrez L, Gabriela Barcenas-Morales, The COVID-19 Genomics UK (COG-UK) consortium, William Harvey, Herbert W. Virgin, Antonio Lanzavecchia, Luca Piccoli, Rainer Doffinger, Mark Wills, David Veesler, Davide Corti, Ravindra K. Gupta
doi: https://doi.org/10.1101/2021.01.19.21249840

Article Information

doi 
https://doi.org/10.1101/2021.01.19.21249840
History 
  • February 15, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Dami A. Collier1,2,3,*,
  2. Anna De Marco4,*,
  3. Isabella A.T.M. Ferreira*,1,2,
  4. Bo Meng1,2,*,
  5. Rawlings Datir*,1,2,3,
  6. Alexandra C. Walls5,
  7. Steven A. Kemp S1,2,3,
  8. Jessica Bassi4,
  9. Dora Pinto4,
  10. Chiara Silacci Fregni4,
  11. Siro Bianchi4,
  12. M. Alejandra Tortorici5,
  13. John Bowen5,
  14. Katja Culap4,
  15. Stefano Jaconi4,
  16. Elisabetta Cameroni4,
  17. Gyorgy Snell6,
  18. Matteo S. Pizzuto4,
  19. Alessandra Franzetti Pellanda7,
  20. Christian Garzoni7,
  21. Agostino Riva8,
  22. The CITIID-NIHR BioResource COVID-19 Collaboration9,
  23. Anne Elmer10,
  24. Nathalie Kingston11,
  25. Barbara Graves11,
  26. Laura E McCoy3,
  27. Kenneth GC Smith1,2,
  28. John R. Bradley2,11,
  29. Nigel Temperton12,
  30. Lourdes Ceron-Gutierrez L13,
  31. Gabriela Barcenas-Morales13,14,
  32. The COVID-19 Genomics UK (COG-UK) consortium15,
  33. William Harvey16,
  34. Herbert W. Virgin6,
  35. Antonio Lanzavecchia4,
  36. Luca Piccoli4,
  37. Rainer Doffinger13,
  38. Mark Wills2,
  39. David Veesler5,
  40. Davide Corti4,*,# and
  41. Ravindra K. Gupta1,2,17,18,19,*,#
  1. 1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
  2. 2Department of Medicine, University of Cambridge, Cambridge, UK
  3. 3Division of Infection and Immunity, University College London, London, UK
  4. 4Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
  5. 5Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
  6. 6Vir Biotechnology, San Francisco, CA 94158, USA
  7. 7Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland
  8. 8Division of Infectious Diseases, Luigi Sacco Hospital, University of Milan, Milan, Italy
  9. 10NIHR Cambridge Clinical Research Facility, Cambridge, UK
  10. 11NIHR Bioresource, Cambridge, UK
  11. 12University of Kent, Canturbury, UK
  12. 13Department of Clinical Biochemistry and Immunology, Addenbrookes Hospital, UK
  13. 14Laboratorio de Inmunologia, S-Cuautitlán, UNAM, Mexico
  14. 16Institute of Biodiversity, University of Glasgow, Glasgow, UK
  15. 17University of KwaZulu Natal, Durban, South Africa
  16. 18Africa Health Research Institute, Durban, South Africa
  17. 19Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge UK
  1. ↵#Correspondence:
    dcorti{at}vir.bio, rkg20{at}cam.ac.uk

  1. ↵* Equal contribution

Back to top
Posted February 15, 2021.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML
Data/Code
Email
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, Bo Meng, Rawlings Datir, Alexandra C. Walls, Steven A. Kemp S, Jessica Bassi, Dora Pinto, Chiara Silacci Fregni, Siro Bianchi, M. Alejandra Tortorici, John Bowen, Katja Culap, Stefano Jaconi, Elisabetta Cameroni, Gyorgy Snell, Matteo S. Pizzuto, Alessandra Franzetti Pellanda, Christian Garzoni, Agostino Riva, The CITIID-NIHR BioResource COVID-19 Collaboration, Anne Elmer, Nathalie Kingston, Barbara Graves, Laura E McCoy, Kenneth GC Smith, John R. Bradley, Nigel Temperton, Lourdes Ceron-Gutierrez L, Gabriela Barcenas-Morales, The COVID-19 Genomics UK (COG-UK) consortium, William Harvey, Herbert W. Virgin, Antonio Lanzavecchia, Luca Piccoli, Rainer Doffinger, Mark Wills, David Veesler, Davide Corti, Ravindra K. Gupta
medRxiv 2021.01.19.21249840; doi: https://doi.org/10.1101/2021.01.19.21249840
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

50

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.